|
Market Closed -
Other stock markets
|
After hours 05:23:08 am | |||
| 25.56 USD | -0.23% |
|
25.58 | +0.06% |
| 09/07 | Major deals involving U.S. drugmakers and biotechs over the past decade | RE |
| 09/07 | Transgene SA Announces Board Changes | CI |
| Capitalization | 15TCr 12TCr 12TCr 11TCr 20TCr 12,45700Cr 22TCr 1,38500Cr 53TCr 5,82000Cr 55TCr 53TCr 21,29500Cr | P/E ratio 2025 * |
12.1x | P/E ratio 2026 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise value | 18TCr 16TCr 15TCr 14TCr 25TCr 15,73300Cr 28TCr 1,74900Cr 67TCr 7,35000Cr 69TCr 67TCr 26,89400Cr | EV / Sales 2025 * |
2.94x | EV / Sales 2026 * | 2.9x |
| Free-Float |
59.04% | Yield 2025 * |
6.68% | Yield 2026 * | 6.82% |
More valuation ratios
* Estimated data
More news
Last Transcript: Pfizer, Inc.
More recommendations
More press releases
More news
| 1 day | +0.06% | ||
| 1 week | +2.08% | ||
| Current month | +5.45% | ||
| 1 month | +9.46% | ||
| 3 months | +17.03% | ||
| 6 months | -4.84% | ||
| Current year | -3.66% |
| 1 week | 25.14 |  | 25.96 |
| 1 month | 23.76 | | 25.96 |
| Current year | 20.92 | | 27.57 |
| 1 year | 20.92 | | 31.54 |
| 3 years | 20.92 | | 54.93 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 63 | 01/01/2019 |
David Denton
DFI | Director of Finance/CFO | 60 | 02/05/2022 |
| Chief Tech/Sci/R&D Officer | - | 24/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 67 | 01/09/2007 |
Shantanu Narayen
BRD | Director/Board Member | 61 | 27/09/2013 |
Albert Bourla
CHM | Chairman | 63 | 01/01/2020 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 14.74% | 378 M€ | -7.14% | - | |
| 9.37% | 21 M€ | +4.14% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.23% | +2.08% | -8.49% | -51.93% | 15TCr | ||
| +1.19% | +1.42% | -14.28% | +138.12% | 70TCr | ||
| +0.31% | +0.23% | +7.42% | -12.34% | 37TCr | ||
| +0.45% | +0.33% | +14.47% | +24.71% | 34TCr | ||
| -1.53% | +1.07% | -55.00% | +10.90% | 31TCr | ||
| +0.89% | -0.27% | +6.69% | -19.23% | 26TCr | ||
| -0.16% | -0.36% | +0.34% | +17.87% | 24TCr | ||
| +0.21% | -0.38% | -13.97% | -6.18% | 22TCr | ||
| +2.88% | +2.32% | -33.45% | -9.78% | 20TCr | ||
| -0.16% | +2.07% | -4.80% | +19.33% | 16TCr | ||
| Average | +0.01% | +0.78% | -10.11% | +11.15% | 29.48TCr | |
| Weighted average by Cap. | +0.01% | +0.59% | -10.05% | +32.22% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 6.24TCr 5.33TCr 4.97TCr 4.6TCr 8.56TCr 5,35200Cr 9.56TCr 59TCr 23TCr 2,50100Cr 23TCr 23TCr 9,14900Cr | 6.22TCr 5.32TCr 4.95TCr 4.58TCr 8.53TCr 5,33500Cr 9.53TCr 59TCr 23TCr 2,49200Cr 23TCr 23TCr 9,12000Cr |
| Net income | 1.21TCr 1.03TCr 961.42Cr 889.18Cr 1.65TCr 1,03500Cr 1.85TCr 12TCr 4.38TCr 48TCr 4.53TCr 4.44TCr 1,77000Cr | 1.33TCr 1.14TCr 1.06TCr 978.78Cr 1.82TCr 1,14000Cr 2.04TCr 13TCr 4.82TCr 53TCr 4.99TCr 4.88TCr 1,94800Cr |
| Net Debt | 3.82TCr 3.26TCr 3.04TCr 2.81TCr 5.24TCr 3,27500Cr 5.85TCr 36TCr 14TCr 1,53000Cr 14TCr 14TCr 5,59900Cr | 3.55TCr 3.03TCr 2.82TCr 2.61TCr 4.86TCr 3,04000Cr 5.43TCr 34TCr 13TCr 1,42000Cr 13TCr 13TCr 5,19600Cr |
More financial data
* Estimated data
Employees
81,000
Sector
Pharmaceuticals
Calendar
25/07
- Détachement de
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/25/09 | 25.56 $ | -0.23% | 3,83,44,114 |
| 08/25/08 | 25.62 $ | +1.51% | 5,12,75,809 |
| 07/25/07 | 25.24 $ | -0.55% | 3,49,05,924 |
| 03/25/03 | 25.38 $ | +0.24% | 2,71,04,580 |
| 02/25/02 | 25.32 $ | +1.12% | 3,67,72,093 |
Delayed Quote Nyse, July 10, 2025 at 01:30 am IST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
25.56USD
Average target price
29.14USD
Spread / Average Target
+14.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition